Matches in Wikidata for { <http://www.wikidata.org/entity/Q91682257> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91682257 description "article scientifique publié en 2019" @default.
- Q91682257 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q91682257 description "im September 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91682257 description "scientific article published on 01 September 2019" @default.
- Q91682257 description "wetenschappelijk artikel" @default.
- Q91682257 description "наукова стаття, опублікована 1 вересня 2019" @default.
- Q91682257 name "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 name "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 type Item @default.
- Q91682257 label "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 label "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 prefLabel "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 prefLabel "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 P1433 Q91682257-94E02A4B-CEB5-46F3-96B8-A79C7FE30E36 @default.
- Q91682257 P1476 Q91682257-B6CBA993-0E11-4AD4-82BB-CDC51C319131 @default.
- Q91682257 P2093 Q91682257-75021482-651A-4547-A3D3-0463536A6E00 @default.
- Q91682257 P2860 Q91682257-50F98705-A0D1-4AF5-BE3F-E22EE5410FED @default.
- Q91682257 P2860 Q91682257-A888D490-35AF-4910-9CE1-95C4CE414B1B @default.
- Q91682257 P2860 Q91682257-D88A7B57-8FD0-4D97-A958-0208F4E40FBF @default.
- Q91682257 P304 Q91682257-56E94986-78CD-4232-B4AD-35481E35CEC8 @default.
- Q91682257 P31 Q91682257-A3B9C09D-BBF8-4FA6-8C44-21BA0BDCD63C @default.
- Q91682257 P356 Q91682257-F305049A-C301-4A0F-B6FC-610C2F36CB45 @default.
- Q91682257 P433 Q91682257-974A10F1-62B3-4596-BC33-EEC510CF17D5 @default.
- Q91682257 P478 Q91682257-3717BF39-08FF-4441-92C9-58115A9954C0 @default.
- Q91682257 P50 Q91682257-4AF92B9F-ECF9-4B5C-AC29-4A243413A40F @default.
- Q91682257 P577 Q91682257-543D2C59-4A7E-47A7-A5CB-723937C0E2CA @default.
- Q91682257 P698 Q91682257-58C490F2-93D0-4928-B128-7A204A3FE2E8 @default.
- Q91682257 P356 HEP.30683 @default.
- Q91682257 P698 31044439 @default.
- Q91682257 P1433 Q15724398 @default.
- Q91682257 P1476 "Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?" @default.
- Q91682257 P2093 "Harshit S Khara" @default.
- Q91682257 P2860 Q57093490 @default.
- Q91682257 P2860 Q59355625 @default.
- Q91682257 P2860 Q93087176 @default.
- Q91682257 P304 "1078-1079" @default.
- Q91682257 P31 Q13442814 @default.
- Q91682257 P356 "10.1002/HEP.30683" @default.
- Q91682257 P433 "3" @default.
- Q91682257 P478 "70" @default.
- Q91682257 P50 Q89906151 @default.
- Q91682257 P577 "2019-09-01T00:00:00Z" @default.
- Q91682257 P698 "31044439" @default.